Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcellx (ACLX) Research & Development (2023 - 2025)

Arcellx (ACLX) has 3 years of Research & Development data on record, last reported at $34.1 million in Q4 2025.

  • For Q4 2025, Research & Development fell 23.64% year-over-year to $34.1 million; the TTM value through Dec 2025 reached $157.6 million, changed 0.33%, while the annual FY2025 figure was $157.6 million, 0.33% changed from the prior year.
  • Research & Development reached $34.1 million in Q4 2025 per ACLX's latest filing, down from $35.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $50.8 million in Q1 2025 and bottomed at $28.3 million in Q2 2023.
  • Average Research & Development over 3 years is $37.4 million, with a median of $36.4 million recorded in 2025.
  • The widest YoY moves for Research & Development: up 57.19% in 2025, down 23.64% in 2025.
  • A 3-year view of Research & Development shows it stood at $28.8 million in 2023, then soared by 55.12% to $44.6 million in 2024, then decreased by 23.64% to $34.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $34.1 million in Q4 2025, $35.1 million in Q3 2025, and $37.6 million in Q2 2025.